Diferencia entre revisiones de «Ketorolac»
| Línea 14: | Línea 14: | ||
==Special Populations== | ==Special Populations== | ||
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: | *[[Drug Ratings in Pregnancy|Pregnancy Rating]]: C | ||
*Lactation: | *Lactation: Enters breast milk, use caution | ||
*Renal Dosing | *Renal Dosing | ||
** | **Mild-Moderate impairment: Decrease dose by 50% | ||
** | **Severe impairment or HD: Contraindicated | ||
*Hepatic Dosing | *Hepatic Dosing: No dose change, but may increase LFTs | ||
==Contraindications== | ==Contraindications== | ||
Revisión del 01:06 23 may 2015
General
- Type: NSAID
- Dosage Forms: 15 mg/mL, 30 mg/mL injection
- Common Trade Names: Toradol
Adult Dosing
- Acute pain:
- IM: 30-60 mg x 1 or 30 mg q6h
- IV: 30 mg x 1, then 15-30 mg q6h
- Black box warning against tx for > 5 days
Pediatric Dosing
- N/A
Special Populations
- Pregnancy Rating: C
- Lactation: Enters breast milk, use caution
- Renal Dosing
- Mild-Moderate impairment: Decrease dose by 50%
- Severe impairment or HD: Contraindicated
- Hepatic Dosing: No dose change, but may increase LFTs
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: